H.R. 124: Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

H.R. 124 is a federal bill in the 119th Congress. Currently, states do not receive specific federal Medicaid funding for educating individuals with sickle cell disease about renal medullary carcinoma. This bill changes that by allowing states to receive federal payment for 50% of the costs they incur for… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.